Israel Englander Entrada Therapeutics, Inc. Transaction History
Millennium Management LLC
- $207 Billion
- Q2 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 147,306 shares of TRDA stock, worth $2.16 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
147,306
Previous 71,946
104.75%
Holding current value
$2.16 Million
Previous $1.02 Million
105.99%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding TRDA
# of Institutions
84Shares Held
27.7MCall Options Held
100Put Options Held
0-
Baker Bros. Advisors LP New York, NY4.87MShares$71.4 Million0.92% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.43MShares$65 Million34.63% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.41MShares$64.7 Million29.39% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.13MShares$46 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.69MShares$24.9 Million0.0% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $460M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...